SAM Chun Dang Pharm
삼천당제약KRX: 000250· Fiscal year 2025· scd.co.kr ↗
Average salary
$49.4K
₩65.8M
▼ 0.9% vs 2024
Employees
436
▲ 4.6% vs 2024
Average tenure
8.3 yrs
Estimated take-home of this pay:$3.4K / monthCalculate →
Workplace
Women's pay (men = 100)67
Women among staff29.8%
Contract staff2.3%
Recent official filings
- 2026-11-13Quarterly report (2026.09)
- 2026-11-02Supply contract signed
- 2026-11-02Supply contract signed
- 2026-08-14Half-year report (2026.06)
- 2026-06-10Investor relations (IR) event
Quick read
- Average pay is 8% above the median of the companies we track.
- Average pay fell 0.9% from 2024.
- Headcount grew by 19 (4.6%) from 2024.
- Ranks #67 of 238 Healthcare & Pharma companies in this country by pay.
- Revenue grew 9.9% year over year.
- Revenue has grown two years in a row.
- Operating margin was 3.7% in 2025.
Last 3 years
Revenue
Operating income
See the share price on Naver Finance ↗
Investor metrics
2025
- Revenue per employee
- $398.1K
- Net profit per employee
- $20.7K
- Operating margin
- 3.7%
- Net margin
- 5.2%
- ROE
- 3.3%
- Debt-to-equity
- 54.4%
- Equity ratio
- 64.8%
- Payout ratio
- 22.1%
- Dividend per share
- $0
- Dividend yield (as disclosed)
- 0.0%
Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.